Oxford BioMedica plc Share Price London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 | 89.54M 112M 9.33B | Sales 2024 * | 130M 162M 13.53B | Capitalization | 277M 346M 28.8B |
---|---|---|---|---|---|
Net income 2023 | -157M -196M -16.35B | Net income 2024 * | -35M -43.78M -3.65B | EV / Sales 2023 | 2.38 x |
Net cash position 2023 * | 49.23M 61.57M 5.13B | Net cash position 2024 * | 13.8M 17.26M 1.44B | EV / Sales 2024 * | 2.02 x |
P/E ratio 2023 |
-1.35
x | P/E ratio 2024 * |
-8.39
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 27/23/27 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 29/17/29 |
Chairman | 68 | 24/20/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 01/23/01 |
Chairman | 68 | 24/20/24 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 01/16/01 |
1st Jan change | Capi. | |
---|---|---|
-0.63% | 102B | |
+3.58% | 96.09B | |
+2.13% | 22.28B | |
-14.71% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.76% | 16.09B | |
+9.56% | 13.83B | |
+34.90% | 11.97B |